Capital Bank & Trust CO Bei Gene, Ltd. Transaction History

Capital Bank & Trust CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $165,292 - $258,911	-665 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $41 Million - $66.2 Million	-164,299 Reduced 99.6%	665 $241,000
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $264,060 - $331,043	902 Added 0.55%	164,964 $56.6 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $540,306 - $792,134	2,073 Added 1.28%	164,062 $57.1 Million
Q4 2020 Feb 16, 2021	BUY	$221.31 - $316.61 $651,536 - $932,099	2,944 Added 1.85%	161,989 $41.9 Million

Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $213,584 - $323,390	1,129 Added 0.71%	159,045 $45.6 Million
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $231,816 - $365,612	-1,871 Reduced 1.17%	157,916 $29.8 Million
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $457,874 - $650,848	-3,758 Reduced 2.3%	159,787 $19.7 Million
Q4 2019 Feb 18, 2020	BUY	$115.78 - $208.34 $484,770 - $872,319	4,187 Added 2.63%	163,545 $27.1 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $2.58 Million - $3.17 Million	-21,376 Reduced 11.83%	159,358 $19.5 Million
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $721,898 - $930,064	6,333 Added 3.63%	180,734 $22.4 Million
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $13.9 Million - $17.2 Million	113,401 Added 185.9%	174,401 $22.9 Million
Q4 2018 Feb 14, 2019	BUY	$107.01 - $175.15 $6.53 Million - $10.7 Million	61,000 New	61,000 $8.56 Million

216

45.1M

76.5K

72.3K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $14.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.